These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 423450)

  • 1. [Peritoneal dialysis with a suspension of allogeneic liver cells in the treatment of liver insufficiency].
    Ostroverkhov GE; Berelavichus VIu; Bruslik VG; Maliugin EF; Shimanko II
    Khirurgiia (Mosk); 1979 Mar; (3):41-6. PubMed ID: 423450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peritoneal dialysis with allogenic hepatic cell suspension in treatment of hepatic insufficiency].
    Kardava I; Chutkerashvili K
    Georgian Med News; 2005 Apr; (121):75-7. PubMed ID: 15908732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic hepatic cell suspension in the treatment of liver insufficiency].
    Ostroverkhov GE; Bruslik VG; Maliugin EF
    Biull Eksp Biol Med; 1978 Mar; 85(3):281-4. PubMed ID: 667321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a suspension of allogeneic liver cells in treating patients with acute liver and liver-kidney failure].
    Komarov BD; Shimanko II; Ostroverkhov GE; Milovanov IuS; Berilavichus VIu
    Khirurgiia (Mosk); 1985 Jan; (1):34-7. PubMed ID: 3974137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute experimental hepatic insufficiency caused by total ischemia of the liver: effect of peritoneal dialysis].
    Cassina I; Reggiori G; Tagliatesta GL; Saba V; Addis F; Mortellaro C; Rusca A; Ferretti A; Pierguidi L; Valenti G; Miradoli R; Quarto di Palo F
    Chir Patol Sper; 1979 Apr; 27(2):153-70. PubMed ID: 555712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative assessment of the use of cellular suspensions of allogenic and xenogenic liver in the treatment of liver failure].
    Ostroverkhov GE; Bruslik VG; Maliugin EF
    Vestn Akad Med Nauk SSSR; 1978; (9):56-61. PubMed ID: 364873
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic and xenogeneic hepatocyte transplantation.
    Makowka L; Rotstein LE; Falk RE; Falk JA; Zuk R; Langer B; Blendis LM; Phillips MJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):855-9. PubMed ID: 7022952
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of isolated living hepatocytes in the treatment of liver failure (review of the literature)].
    Margulis MS; Erukhimov EA
    Khirurgiia (Mosk); 1985 Mar; (3):150-3. PubMed ID: 3889470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracorporeal dialysis in liver failure].
    Ostroverkhov GE; Berklavichus VIu; Bruslik VG
    Eksp Khir Anesteziol; 1976; (4):41-5. PubMed ID: 1022439
    [No Abstract]   [Full Text] [Related]  

  • 10. Further evidence on thymus-mediated tolerance to cellular alloantigens.
    Lengerová A; Vojtísková M; Zelený V
    Folia Biol (Praha); 1967; 13(6):469-72. PubMed ID: 4865457
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic significance of hepatocytes in tolerance induction after liver transplantation.
    Nakano H; Nakajima Y; Segawa M; Kanehiro H; Murao Y; Nakagawa K; Shiratori T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):511-3. PubMed ID: 3274815
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antirat hepatic serum on rats--a histopathological study.
    Sharma V; Pratap VK; Mishra SD
    J Postgrad Med; 1986 Jan; 32(1):32-6. PubMed ID: 3746708
    [No Abstract]   [Full Text] [Related]  

  • 14. The liver mediates apoptotic cell-induced immune regulation.
    Wang Y; Gao Y; Yuan X; Xia W; Luo Y; Sun E; Chen ZK
    Scand J Immunol; 2008 Sep; 68(3):297-305. PubMed ID: 18782258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
    Lin YC; Chen CL; Nakano T; Goto S; Kao YH; Hsu LW; Lai CY; Jawan B; Cheng YF; Tateno C; Yoshizato K
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e243-50. PubMed ID: 17645734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of rats for rejection of heart allografts by heterotopic auxiliary liver grafting or administration of liver cell suspensions.
    Kamada N; Müller GH; Katami M; Tamaki T; Baguerizo A; Shinomiya T
    Transplantation; 1985 Jul; 40(1):106-8. PubMed ID: 3892788
    [No Abstract]   [Full Text] [Related]  

  • 17. Strong tolerance mediated by allografting in the rat is due to donor liver leukocytes.
    Sun J; Sheil R; McCaughan G; Jung S; Gallagher N; Bishop G
    Transplant Proc; 1995 Dec; 27(6):3578. PubMed ID: 8540110
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated parabiosis in mice: immunological and haematological sequelae, and demonstration of a hybrid-anti-parent reaction.
    Myburgh JA
    Transplantation; 1968 May; 6(3):400-10. PubMed ID: 4871397
    [No Abstract]   [Full Text] [Related]  

  • 19. [The internal bioartifical liver].
    Benoist S; Nordlinger B
    J Soc Biol; 2001; 195(1):91-6. PubMed ID: 11530509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The liver--an immunologically privileged organ?].
    Jahr H; Wolff H
    Allerg Immunol (Leipz); 1989; 35(3):155-66. PubMed ID: 2479248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.